Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 2.

Availability of the Novel Drugs Recommended in the Guidelines for Irritable Bowel Syndrome With Constipation and Irritable Bowel Syndrome With Diarrhea in Each Asian Country (as of the Lecture of Professor Yong Sung Kim in 7th Biennial Congress of the Asian Neurogastroenterology and Motility Association, 11 November 2023)

Drug
Country		 IBS-C IBS-D
Linaclotide Plecanatide Tenapanor Lubiprostone Tegaserod Prucalopride Eluxadoline Rifaximin Alosetron Ramosetron
Hong Kong ○ ✕ ✕ ✕ ✕ ○ ✕ ○ ✕ ✕
India ✕ ✕ ✕ ○ ○→✕ ○ ✕ ○ ✕ ○
Japan ○ ✕ ✕ ○ ✕ ✕ ✕ ○ ✕ ○
Malaysia ✕ ✕ ✕ ✕ ✕ ○ ✕ ○ ○ ✕
Korea ✕ ✕ ✕ ○→✕ ○→✕ ○ ✕ ○ ✕ ○
Singapore ○ ✕ ✕ ○ ○ ○ ✕ ○ ✕ ✕
Taiwan ✕ ✕ ✕ ✕ ✕ ○→✕ ✕ ✕ ✕ ✕
Thailand ✕ ✕ ✕ ○→✕ ○→✕ ○ ✕ ✕ ✕ ○→✕
Vietnam ✕ ✕ ✕ ✕ ✕ ✕ ✕ ○→✕ ✕ ✕

IBS-C, irritable bowel syndrome with constipation; IBS-D, irritable bowel syndrome with diarrhea; ○, available; ✕, not available; ○→✕, previously available, but not currently available.
J Neurogastroenterol Motil 2024;30:4~6 https://doi.org/10.5056/jnm23183
© J Neurogastroenterol Motil